Search results for "letter"

showing 10 items of 4021 documents

Comment on "Antipsoriatic treatments during COVID-19 outbreak".

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDermatologyBetacoronavirusCOVID‐19PandemicMedicineHumansPsoriasisLettersPandemicsbiologybusiness.industrySARS-CoV-2OutbreakCOVID-19General Medicinebiology.organism_classificationVirologyTherapybusinessCoronavirus InfectionsCoronavirus InfectionsBetacoronavirusImmunosuppressive AgentsDermatologic therapy
researchProduct

The COVID-19 outbreak and rheumatologic skin diseases.

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryClinical Laboratory TechniquesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEOutbreakCOVID-19DermatologyGeneral MedicineVirologySkin DiseasesDisease OutbreaksArthritis RheumatoidCOVID-19 TestingRisk FactorsMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Solidarity and transparency against the COVID ‐19 pandemic

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryDeveloped CountriesInternational CooperationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralCOVID-19DermatologyGeneral MedicinePublic administrationTransparency (behavior)SolidarityPandemicHumansMedicineLettersCoronavirus InfectionsbusinessDelivery of Health CareDeveloping CountriesPandemicsDermatologic Therapy
researchProduct

Asymptomatic SARS-CoV-2 infection and CT lung lesions: how reliable is the hypothesised association?

2021

2019-20 coronavirus outbreakLungmedicine.anatomical_structureCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicineGeneral Medicinemedicine.symptombusinessAsymptomaticVirologyLetter to the EditorBJR Open
researchProduct

Diabetes is not associated with COVID-19-related mortality in older institutionalized people

2021

Diabetes & Metabolism - Sous presse. Manuscrit accepte. Disponible en ligne depuis le mercredi 27 janvier 2021

2019-20 coronavirus outbreakPediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industryEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINE030209 endocrinology & metabolismGeneral Medicine030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal MedicineMedicineLetters to the EditorbusinessDiabetes & Metabolism
researchProduct

MULTI-COMPONENT REHABILITATION AFTER COVID-19 FOR NURSING HOME RESIDENTS

2021

2019-20 coronavirus outbreakRehabilitationCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industryHumans Nursing Homes SARS-CoV-2 COVID-19Health PolicySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.medical_treatmentCOVID-19General Medicinenutritional interventionNursing Homesnursing homeNursingdisabilitymedicineHumansGeriatrics and GerontologyNursing homesbusinessLetter to the EditorGeneral NursingJournal of the American Medical Directors Association
researchProduct

Atypical thrombosis associated with VaxZevria (R) (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres

2021

The current COVID-19 pandemic is an exceptional health situation including for drug use. As there was no known effective drug for COVID-19 at the beginning of the pandemic, different candidates were proposed. In this short article, we present the French public pharmacovigilance activities during this health crisis. Although COVID-19 is a confounding factor per se, owing to its potential for multi-organ damage including the heart and kidney, the quality of the transmitted data in adverse drug reaction reports, the timeliness of feedback from clinicians, and the real-time pharmacological and medical analysis by the French network of the regional pharmacovigilance centers made it possible to s…

2019-20 coronavirus outbreakTime FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)[SDV]Life Sciences [q-bio]Letter to EditorAntiviral AgentsPharmacovigilancePharmacovigilancemedicineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)PandemicsComputingMilieux_MISCELLANEOUSCovid-19 vaccineSARS-CoV-2business.industryCOVID-19VaxZevria®medicine.diseaseAtypical thrombosisThrombosisVirology[SDV] Life Sciences [q-bio]Anti-PF4 antibodiesFrancebusinessThrombopenia
researchProduct

The Fast Territorial Expansion of COVID-19 in Spain.

2020

2019-20 coronavirus outbreaklcsh:R5-920Coronavirus disease 2019 (COVID-19)Epidemiologybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineInternational HealthGeneral Medicinebusinesslcsh:Medicine (General)VirologyLetter to the EditorJournal of epidemiology
researchProduct

Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study

2021

N/A

2019-20 coronavirus outbreakmedicine.medical_specialtyAcademicSubjects/MED00910Coronavirus disease 2019 (COVID-19)medicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)pandemicsNOPandemicResearch LettermedicinehumansThyroid cancerThyroid NeoplasmLS7_4Thyroid Neoplasms; Thyroidectomy; SARS-CoV-2; COVID-19; Pandemics; ItalyPandemicbusiness.industrySARS-CoV-2thyroid neoplasmsThyroidectomyCOVID-19Retrospective cohort studymedicine.diseaseComorbidityCOVID-19; comorbidity; humans; Italy; retrospective studies; SARS-CoV-2; thyroid neoplasms; pandemics; thyroidectomySettore MED/18 - Chirurgia Generalecomorbidityretrospective studiesItalyEmergency medicinethyroidectomyThyroidectomySurgeryAcademicSubjects/MED00010business
researchProduct

Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey

2021

2019-20 coronavirus outbreakmedicine.medical_specialtyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Directive CounselingInternal medicineHumansImmunology and AllergyMedicineFamilyPhysician's RoleLetter to the EditorAcademicSubjects/MED00260Ibdjnl/1SARS-CoV-2business.industryGastroenterologistsVaccinationAge FactorsGastroenterologyCOVID-19Inflammatory Bowel DiseasesPatient Acceptance of Health CareInflammatory Bowel DiseasesVaccinationItalyInfluenza VaccinesCohortbusinessAttitude to HealthInflammatory Bowel Diseases
researchProduct